You have 9 free searches left this month | to do more

tl-895

Tl 895 is a drug used to treat Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, and other conditions. Tl 895 is being actively studied in 6 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Telios Pharma, Inc.Gabrail Cancer Center
Kartos Therapeutics, Inc.Military Medical Academy
UMHAT Georgi Stranski
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
K
Recruiting
  • Myelofibrosis
  • +3 more
  • Whittier, California
  • +8 more
2021-06-11
Jun 11, 2021
K
Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Glendale, California
  • +22 more
2021-10-30
Oct 30, 2021
T
Active, not recruiting
  • Relapsed/Refractory B Cell Malignancies
  • +3 more
  • TL-895
  • Columbus, Ohio
  • +17 more
2022-03-05
Mar 5, 2022
T
Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +32 more
2022-03-05
Mar 5, 2022
T
Recruiting
  • Myelofibrosis
  • TL-895
  • Aurora, Colorado
  • +63 more
2022-03-05
Mar 5, 2022